PRKAA1 and metabolic syndrome: The modifiable major risk factors that lead to CVD are excess weight, dyslipidemia, increased blood pressure, diabetes, and metabolic syndrome, in which AMPK activators may confer benefits (Nellaiappan et al., 2019).